COMMUNIQUÉS West-GlobeNewswire

Cronos Group Inc. to Hold Virtual 2026 Annual Meeting of Shareholders
29/04/2026
TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2026 Annual Meeting of Shareholders on Thursday, June 18, 2026, at 11:00 a.m. ET. Cronos [...]
Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results
29/04/2026
MALVERN, Pa., April 29, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a [...]
Cannabis Growers Are Shifting Priorities: Seed Banks to Watch in 2026, According to SeedFinder.eu
29/04/2026
Grower trends, F1 hybrids and top breeders shaping the cannabis seed market in 2026 BARCELONA, Spain, April 29, 2026 (GLOBE NEWSWIRE) -- Grower priorities are shifting in 2026. New data from SeedFinder.eu shows that, [...]
Emergent BioSolutions Secures Long-Term Strategic Manufacturing Contract with SAB Biotherapeutics to Advance Type 1 Diabetes Candidate, SAB-142
29/04/2026
GAITHERSBURG, Md., April 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a multi-year agreement with SAB Biotherapeutics, Inc. (Nasdaq: SABS , SAB BIO) to support the process [...]
GH Research Announces Pricing of $117.5 Million Underwritten Offering
29/04/2026
DUBLIN, April 29, 2026 (GLOBE NEWSWIRE) -- GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment in [...]
Doheny Eye Institute Researchers to Share Cutting-Edge Vision Science Across More Than 20 Sessions at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting
29/04/2026
Doheny scientists, clinician-scientists, and research fellows will present findings on eye disease, advanced imaging, artificial intelligence and more at the preeminent global vision research conference PASADENA, Calif [...]
Calidi Biotherapeutics Announces Strategic Partnership with TransferAI to Drive Efficiencies in the IND Submission Process for CLD-401 Using Agentic AI
29/04/2026
SAN DIEGO, April 29, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, announced [...]
Tacalyx Secures €11 Million to Advance Lead TACA-Targeting ADC Programme Toward the Clinic
29/04/2026
Tacalyx Secures €11 Million to Advance Lead TACA-Targeting ADC Programme Toward the Clinic Berlin, Germany, April 29, 2026 (GLOBE NEWSWIRE) -- Tacalyx, a leader in the discovery and development of cancer therapies [...]
Inspire Medical Systems, Inc. to Present at the BofA Securities 2026 Healthcare Conference
29/04/2026
MINNEAPOLIS, April 29, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
Ontario Building Code Review Points to a Clear Win for Families and Future Homeowners: Prevent Lung Cancer Cases by Keeping Radon Mitigation Measures in Place
29/04/2026
Lung Health Foundation says existing protections are simple, effective safeguards worth preserving TORONTO, April 29, 2026 (GLOBE NEWSWIRE) -- As Ontario moves to speed up housing construction by cutting red tape, Lung [...]
Autonomix Medical Announces Abstract Acceptance at Digestive Disease Week 2026 Showcasing Long-Term Data in Pancreatic Cancer Pain Mitigation
29/04/2026
THE WOODLANDS, TX, April 29, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today [...]
Picard Medical / SynCardia Featured in Interview Series with The Mullings Group
29/04/2026
– Discussions to highlight total artificial heart therapy, advanced heart failure market, and next-generation platform development – TUCSON, Ariz., April 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American [...]
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies
29/04/2026
Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory Momentum Seven Approved Phase 2a Human Clinical Trials Expected to Begin Patient [...]
Silo Pharma’s PTSD Program Advances as FDA Fast-Tracks Psychedelic Therapies for PTSD
29/04/2026
Federal initiatives focused on PTSD and related conditions appears to validate need for new and novel approaches to mental health treatment SARASOTA, Fla, April 29, 2026 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ: [...]
SkinHealth Systems to Report First Quarter 2026 Financial Results on May 7, 2026
29/04/2026
LONG BEACH, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (formerly The Beauty Health Company; Nasdaq: SKIN), a global medical aesthetics company, today announced it will report first quarter 2026 [...]
MindBio Files Patent Applications in 15 World Firsts
29/04/2026
Using Voice and AI to Detect Drug & Alcohol Intoxication 15 world first discoveries transform our understanding of physiological reactions to neurologically active substances that when consumed, affect the central [...]
Anika Reports First Quarter 2026 Financial Results
29/04/2026
Grew total company revenue 13%, driven by Commercial Channel strength and favorable OEM Channel order timing Delivered 64% gross margin, +8 points year over year, driven by improved operational execution Operational [...]
Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045
29/04/2026
New U.S. utility patent application targeting patient populations with demonstrated heightened responsiveness to ondansetron treatment, reinforcing Adial’s precision-medicine approach GLEN ALLEN, Va., April 29, 2026 ( [...]
EnteroBiotix Secures £19m to Initiate Phase 2b Clinical Trial for Irritable Bowel Syndrome
29/04/2026
Funds will support one of the largest interventional clinical trials of a full-spectrum microbiome product, and the largest ever to be conducted in IBS Dosing of first patient of the Phase 2b ‘RISE’ trial anticipated in [...]

Pages